David Morrow to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications David Morrow has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.072
-
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention. J Am Coll Cardiol. 2017 Feb 28; 69(8):911-921.
Score: 0.072
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.